β1 integrin deletion enhances progression of prostate cancer in the TRAMP mouse model

被引:16
|
作者
Moran-Jones, Kim [1 ]
Ledger, Anita [1 ]
Naylor, Matthew J. [1 ,2 ,3 ]
机构
[1] St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia
[2] Univ Sydney, Sch Med Sci, Discipline Physiol, Sydney, NSW 2006, Australia
[3] Univ Sydney, Sch Med Sci, Bosch Inst, Sydney, NSW 2006, Australia
来源
SCIENTIFIC REPORTS | 2012年 / 2卷
基金
英国医学研究理事会;
关键词
BETA(1A) INTEGRIN EXPRESSION; ALPHA(2)BETA(1) INTEGRIN; TERMINAL DIFFERENTIATION; 3-DIMENSIONAL CULTURES; CELL-PROLIFERATION; TRANSGENIC MOUSE; MAMMARY-GLAND; IN-VIVO; GROWTH; PROTEIN;
D O I
10.1038/srep00526
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
beta 1 integrin regulates the response of both normal and cancer cells to their local environment. Although mis-localised in prostate cancer, the role beta 1 integrin plays in prostate development and carcinogenesis remains unknown. To assess the role of beta 1 integrin in vivo, we conditionally deleted beta 1 integrin from prostate epithelium and subsequently crossed these mice to the TRAMP prostate carcinogenesis model. Deletion of beta 1 integrin following castration and subsequent androgen supplementation resulted in an expansion of the p63-positive basal cell population and decreased differentiation. Consistent with these findings, deletion of beta 1 integrin in TRAMP mice decreased animal survival, decreased retention of normal prostate morphology, increased the percentage of tissue with poorly differentiated carcinoma, and increased cell proliferation. This study demonstrates that beta 1 integrin regulates several aspects of normal prostate development and in contrast to its role in several other tissues, its loss is associated with increased rates of prostate tumour progression.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Iodine Uptake and Prostate Cancer in the TRAMP Mouse Model
    Olvera-Caltzontzin, Paloma
    Delgado, Guadalupe
    Aceves, Carmen
    Anguiano, Brenda
    MOLECULAR MEDICINE, 2013, 19 : 409 - 416
  • [2] Will metformin postpone high-fat diet promotion of TRAMP mouse prostate cancer development and progression?
    Xu, Hua
    Hu, Meng-bo
    Bai, Pei-de
    Zhu, Wen-hui
    Ding, Qiang
    Jiang, Hao-wen
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (12) : 2327 - 2334
  • [3] The role of SPARC in the TRAMP model of prostate carcinogenesis and progression
    Said, N.
    Frierson, H. F., Jr.
    Chernauskas, D.
    Conaway, M.
    Motamed, K.
    Theodorescu, D.
    ONCOGENE, 2009, 28 (39) : 3487 - 3498
  • [4] Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) model: A good alternative to study PCa progression and chemoprevention approaches
    Kido, Larissa Akemi
    Lamas, Celina de Almeida
    Marostica, Mario Roberto, Jr.
    Alves Cagnon, Valeria Helena
    LIFE SCIENCES, 2019, 217 : 141 - 147
  • [5] Systemic alkalinisation delays prostate cancer cell progression in TRAMP mice
    Astigiano, Simonetta
    Puglisi, Andrea
    Mastracci, Luca
    Fais, Stefano
    Barbieri, Ottavia
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2017, 32 (01) : 363 - 368
  • [6] Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea
    Almendros, I.
    Montserrat, J. M.
    Ramirez, J.
    Torres, M.
    Duran-Cantolla, J.
    Navajas, D.
    Farre, R.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 39 (01) : 215 - 217
  • [7] The Ron receptor promotes prostate tumor growth in the TRAMP mouse model
    Thobe, M. N.
    Gray, J. K.
    Gurusamy, D.
    Paluch, A. M.
    Wagh, P. K.
    Pathrose, P.
    Lentsch, A. B.
    Waltz, S. E.
    ONCOGENE, 2011, 30 (50) : 4990 - 4998
  • [8] The Thoc1 Ribonucleoprotein and Prostate Cancer Progression
    Chinnam, Meenalakshmi
    Wang, Yanqing
    Zhang, Xiaojing
    Gold, David L.
    Khoury, Thaer
    Nikitin, Alexander Yu
    Foster, Barbara A.
    Li, Yanping
    Bshara, Wiam
    Morrison, Carl D.
    Ondracek, Rochelle D. Payne
    Mohler, James L.
    Goodrich, David W.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (11):
  • [9] The effects of glycemic index on prostate cancer progression in a xenograft mouse model
    Galvan, Gloria Cecilia
    Macias, Everardo
    Sanders, Sergio
    Ramirez-Torres, Adela
    Stock, Shannon
    You, Sungyong
    Riera, Celine E.
    Tamukong, Patrick
    Smith-Warner, Stephanie A.
    Genkinger, Jeanine M.
    Luthringer, Daniel J.
    Freeman, Michael R.
    Freedland, Stephen J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 27 (02) : 348 - 354
  • [10] Hepsin Cooperates With MYC in the Progression of Adenocarcinoma in a Prostate Cancer Mouse Model
    Nandana, Srinivas
    Ellwood-Yen, Katharine
    Sawyers, Charles
    Wills, Marcia
    Weidow, Brandy
    Case, Thomas
    Vasioukhin, Valeri
    Matusik, Robert
    PROSTATE, 2010, 70 (06): : 591 - 600